baicalin has been researched along with Nervous System Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| An, N; Gao, Y; Li, Y; Song, K; Sun, Y; Wang, L; Wei, Y; Xing, Y; Yuan, M; Zhang, H | 1 |
| Chen, H; Chen, X; Guan, B; Li, C; Liu, KJ; Qi, S; Qiu, J; Shen, J; Yang, D | 1 |
| Chen, L; Dai, J; Jia, F; Jiang, JY; Li, SQ; Qiu, YM; Xiong, WH; Yin, YH | 1 |
1 review(s) available for baicalin and Nervous System Disorders
| Article | Year |
|---|---|
Anti-inflammatory and immunomodulatory effects of baicalin in cerebrovascular and neurological disorders.
Topics: Animals; Anti-Inflammatory Agents; Cerebrovascular Disorders; Flavonoids; Immunologic Factors; Nervous System Diseases | 2020 |
2 other study(ies) available for baicalin and Nervous System Disorders
| Article | Year |
|---|---|
Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood-Brain Barrier; Capillary Permeability; Cell Hypoxia; Cells, Cultured; Disease Models, Animal; Fibrinolytic Agents; Flavonoids; Glial Fibrillary Acidic Protein; Glucose; Infarction, Middle Cerebral Artery; Intracranial Hemorrhages; Male; Matrix Metalloproteinase 9; Nervous System Diseases; Rats; Rats, Sprague-Dawley; Signal Transduction; Stroke; Tissue Plasminogen Activator; Treatment Outcome | 2018 |
Activations of GABAergic signaling, HSP70 and MAPK cascades are involved in baicalin's neuroprotection against gerbil global ischemia/reperfusion injury.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Flavonoids; Gene Expression Regulation; Gerbillinae; Hippocampus; HSP70 Heat-Shock Proteins; K Cl- Cotransporters; Male; MAP Kinase Signaling System; Nervous System Diseases; Neuroprotective Agents; Phosphopyruvate Hydratase; Receptors, GABA; Reperfusion Injury; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 2; Symporters | 2013 |